« Back
Home /
EDEM2 Antibody, FITC conjugated

EDEM2 Antibody, FITC conjugated

Item no.	CSB-PA861146LC01HU-50ug
Manufacturer	Cusabio
Amount	50 ug
Quantity options	100 ug 50 ug
Category	Oncology Antibodies By Cell Type Carcinoma Sarcoma ELISA Primary Antibodies Immunostaining
Type	Antibody Polyclonal
Format	Liquid
Applications	ELISA
Specific against	Human (Homo sapiens)
Host	Rabbit
Isotype	IgG
Conjugate/Tag	FITC
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	bA4204.1 antibody,C20orf31 antibody,C20orf49 antibody,EDEM 2 antibody,EDEM2 antibody,EDEM2_HUMAN antibody,ER degradation enhancer mannosidase alpha like 2 antibody,ER degradation enhancing alpha mannosidase like 2 antibody,ER degradation enhancing alpha mannosidase like protein 2 antibody,ER degradation enhancing mannosidase like protein 2 antibody,ER degradation-enhancing alpha-mannosidase-like 2 antibody,FLJ10783 antibody,UNQ573/PRO1135 antibody
Similar products	EDEM2, ER degradation-enhancing alpha-mannosidase-like protein 2, C20orf31 C20orf49
Available
Manufacturer - Type	Polyclonal Antibody
Manufacturer - Targets	EDEM2
Storage Conditions	Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Manufacturer - Alias	bA4204.1 antibody, C20orf31 antibody, C20orf49 antibody, EDEM 2 antibody, EDEM2 antibody, EDEM2_HUMAN antibody, ER degradation enhancer mannosidase alpha like 2 antibody, ER degradation enhancing alpha mannosidase like 2 antibody, ER degradation enhancing alpha mannosidase like protein 2 antibody, ER degradation enhancing mannosidase like protein 2 antibody, ER degradation-enhancing alpha-mannosidase-like 2 antibody, FLJ10783 antibody, UNQ573/PRO1135 antibody
Immunogen Species	Human
Immunogen	Recombinant Human ER degradation-enhancing alpha-mannosidase-like protein 2 protein (22-300AA)
Background	Initiates the endoplasmic reticulum-associated degradation (ERAD) that targets misfolded glycoproteins for degradation in an N-glycan-dependent manner. Catalyzes the first mannose trimming step, from Man9GlcNAc2 to Man8GlcNAc2 (PubMed:25092655). Extracts misfolded glycoproteins, but not glycoproteins undergoing productive folding, from the calnexin cycle.
Buffer	Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Purification Method	>95%, Protein G purified
General Research Areas	Signal Transduction
Initial Research Areas	Signal Transduction
Antigen Species	Human
Antigen	Recombinant Human ER degradation-enhancing alpha-mannosidase-like protein 2 protein (22-300AA)
Clonality	Polyclonal

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

CSB-PA861146LC01HU-50ug-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50 ug

available

Delivery expected until 12/25/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer